Alternatives to Pairx
Pairx is a Drug Discovery tool: biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens. Here are the 51 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Drug Discovery companies to Pairx
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BioNTechNot ratedGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Sinopia BiosciencesNot ratedBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Waypoint BioNot ratedAI-native biotech company designing next-generation CAR T therapies for solid tumors.
Kamada PharmaceuticalsNot ratedGlobal biopharmaceutical company specializing in plasma-derived therapeutics for rare and serious conditions.
LTZ TherapeuticsNot ratedImmunotherapy company targeting oncology and autoimmune diseases.
Isomorphic Labs3.0 out of 5 (1)AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.
- GEGenexineNot rated
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
WuXi AppTecNot ratedGlobal CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.
Signadori BioNot ratedDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
Adaptimmune TherapeuticsNot ratedBiopharmaceutical company developing T-cell therapies for solid tumor cancers.
ImmunityBioNot ratedA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Sutro BiopharmaNot ratedClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
Showing the next 20 closest matches. See the rest on the Pairx profile.
Sponsored rows are paid and labelled. Advertise on this page
